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Simple Summary: Various negative factors contribute to a decline in insect pollinators. The aim of
this study was to assess the impact of commercial probiotic EM® PROBIOTIC FOR BEES on honey
bees. The study was conducted in field and laboratory-controlled conditions. In the field, the sugar
syrup with 10% of probiotic was administered by spraying or feeding the honey bee colonies in
order to evaluate the colonies’ strength and Nosema spp. infection levels. In the laboratory, the adult
workers have been fed with sugar syrup supplemented with 2.5, 5, and 10% of EM® for bees for
biochemical and immunological analyses of hemolymph, and with 5 and 10% for measuring the
size of hypopharyngeal glands. It was found that following the EM® for bees administration the
Nosema spp. spore counts in colonies were significantly reduced, and colonies’ strength was increased.
The results at the individual level showed positive physiological changes in treated groups of adult
bees, but, at the same time, a higher mortality rate. Our findings indicate that the EM® for bees is
a promising food additive for nosemosis combating. Therefore, additional emphasis needs to be
placed on studies investigating the nutritional requirements crucial to improve and sustain honey bee
colonies health.
Abstract: Several negative factors contribute to a decline in the number of insect pollinators. As a
novel approach in therapy, we hypothesize that the EM® for bees could potentially have an important
therapeutic and immunomodulatory effect on honey bee colonies. The aim of our study was to
evaluate its impact on honey bees at the individual and colony level. This is the first appliance of the
commercial probiotic mix EM® PROBIOTIC FOR BEES in honey bees as economically important
social insects. The sugar syrup with 10% of probiotic was administered by spraying or feeding the
honey bee colonies in the field conditions, in order to evaluate the infection levels with spores of
Nosema spp. and colonies’ strength. Moreover, in laboratory-controlled conditions, in the hoarding
cages, adult workers have been fed with sugar syrup supplemented with 2.5, 5, and 10% of EM® for
bees for biochemical and immunological analyses of hemolymph, and with 5 and 10% for measuring
the size of hypopharyngeal glands. It was found that following the EM® for bees administration
the Nosema spp. spore counts in colonies were significantly reduced, and colonies’ strength was
increased. The results at the individual level showed significant positive physiological changes in
treated groups of adult bees, revealing at the same time a higher mortality rate when feeding sugar
syrup supplemented with the probiotic.
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1. Introduction
An alarming decline of insect pollinators’ population has been reported globally in the recent
years [1–3]. The honey bees, among them, are probably the most important species from an
ecological and economical aspect [4]. Pollination with honey bees has become a crucial component in
agriculture technology [5,6]. Several environmental factors are suspected to have a negative impact
on their colony strength and probability of their survival. Multiple causal factors are considered
to contribute to colony losses: parasites and pathogens as the main candidates [3,7], exposure to
pesticides [8–11], diet quantity, quality and diversity [12,13], as well as unfavorable weather and forage
circumstances. Moreover, the health status of honey bee colonies is highly influenced by the beekeeper’s
management practices [14,15]. All of these factors affect honey bee colonies individually or in various
combinations [16], possible causing severe disturbance of honey bee microbiota composition. The honey
bee hindgut contains a highly consistent bacterial community of six to nine species clusters which
comprise the core of gut bacteria integrated in the host’s physiological ecosystem and could alter with
the age of adult honey bees [17,18]. Adult honey bee dysbiosis (gastrointestinal microbial imbalance) is
linked to a lower body weight, deficient development, and early workers mortality [19]. Furthermore,
the altered microbiota is associated with host deficiencies. In such situation, the environmental stressors
could change the gut bacterial balance and lead to visible manifestation of opportunistic diseases
and other issues linked with honey bee colony declines [20]. Among them the increased number of
Nosema spp. spores in the midgut, premature foragers senescence, and immune suppression linked
with oxidative stress were reported [21].
Probiotic microorganisms compete with pathogenic microbes in the gastrointestinal tract of honey
bees in adhesion to the intestinal epithelium [22]; protection against pathogens [19]; effects on immune
response and metabolism [23–28], as well as impact to growth, development, and survival rates [19,29].
The presence of probiotics can result in a better availability and utilization of nutrients in honey
bees. Published studies vary in their approaches concerning the effect of commercial probiotics and
prebiotics on honey bee health. Some data have shown that probiotics increase honey bee mortality
and pathogen loads, whereas others suggest that the administration of probiotics has an excellent effect
on the strength of honey bee colonies, wax gland development, honey production, and protection
against diseases [30–37]. The strains of probiotic bacteria that have been mostly used as a novel option
for the management of honey bee microbiome were Bifidobacterium spp. and Lactobacillus spp. [32,38].
Nosemosis type C caused by the microsporidium Nosema ceranae adversely affects the honey bee
health and can result in the complete colony collapse. Further studies on the potential treatment or
beekeeping techniques are urgently required to combat the rapid spread of this dangerous disease.
The role of this pathogen in global colony losses remains controversial [39,40], but a shortened
lifespan due to the energetic stress of individual adult bees, consequent decreased colony strength,
and even possible sudden collapses have been noticed [41,42]. Nosema spp. primary parasites and
replicates within the epithelium of midgut and consequently impairs digestion and absorption of
nutrients [43]. The result of the described parasitism is exacerbated nutritional stress where a causative
agent relies on the host to furnish energy for reproduction and growth [44]. A recently published
study has shown the correlation between nutrition-related gut bacterial dysbiosis in A. mellifera and
the N. ceranae infection [19]. A negative influence of the mentioned factors on honey bee production
and beekeeping management or profitability in general, have driven the development of sustainable
alternative strategies for nosemosis type C therapy. The antibiotic fumagillin has been widely used
in the treatment of nosemosis for a few decades [45]. However, as recently reported, fumagillin may
exacerbate, rather than suppress, N. ceranae infection [46]. In addition, the use of antibiotics in the
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treatment of apian diseases is currently not approved by the European Union regulations. Today,
there is not a single registered authorized veterinary medicine product (VMP) for nosemosis control
and therefore the need for alternative therapies is bigger than ever.
EM®, commercially available as EM® PROBIOTIC FOR BEES (hereinafter, EM® for bees), is a
proprietary probiotic formulation owned and managed by the EM Research Organization in Okinawa,
Japan. It contains multiple species of lactic acid bacteria, yeast, and photosynthetic bacteria. As a
novel approach in therapy, we hypothesize that EM® for bees could have an important therapeutic
and immunomodulatory effect at the individual and colony level. The aim of the current study was to
evaluate the impact of multiple supplemental feedings of naturally diseased honey bee colonies in
apiary conditions, on Nosema spp. infection levels. The obtained results were related with the strength
of experimental colonies. At the same time, in laboratory-controlled conditions, several biochemical
and immunological parameters were measured in hemolymph and hypopharyngeal glands (HPGs) of
newly emerged workers in cages, after multiple supplemental feedings. This is the first appliance of
commercial probiotic mix EM® for bees in honey bees as economically important social insects.
2. Materials and Methods
2.1. Field Test
2.1.1. Locations of Experimental Apiaries and Field Trail Design
The field part of the experiment was conducted during 40 consecutive days (beginning at
1 July 2019) at the apiary situated in the continental part of Croatia (45◦56′54.71′′ N, 16◦37′46.06′′
E), and according to the National classification space units for statistical needs NUTS 2–HR04 and
NUTS 3–HR045, after the main harvesting season. In order to perform the field test, approximately
12 homogeneous honey bee colonies (Apis mellifera carnica, Pollmann, 1879) naturally infected with
Nosema spp. and accommodated in standard Langstroth Root (LR) hives acquired from the same
beekeeper, were selected and divided into experimental (2 × 4) and control (2 × 2) groups. At the
beginning of the study none of the colonies showed clinical signs of brood diseases and the last treatment
against the mite Varroa destructor was carried out at 20 June 2019 (CheckMite®, a.m. coumaphos) to
avoid the negative effects of mite parasitation on colony health. No insecticides were used in the
surrounding area during the experiment.
2.1.2. Supplemental Feed Treatments and Adult Honey Bees Sampling
Honey bee colonies were additionally fed with a 0.25 L sugar syrup (1:1 water-sugar; Virosecer,
Virovitica, Croatia) supplemented with an experimental concentration of 10% of EM® for bees, every
second day. The supplemented sugar syrup, as well as the pure sugar syrup, were administered to
honey bee colonies as follows: experimental colonies (1–4) by spraying directly on frames covered with
adult honey bees (a), and in feeders situated under the roof of the hives (5–8) (b), consecutively during
21 days. The pertaining control groups (control a, b) received only 0.25 L of sugar syrup prepared
and provided in the same described way. The dose was adapted according to the manufacturer’s
instructions. During the clinical inspection of honey bee colonies, approximately 60 forager bees per
colony were collected from the hive entrance for a microscope examination on the presence of Nosema
spp. spores. Adult bee samples were collected into clean plastic receptacles by catching the bees in
front of hives entrances directly or using long tweezers. Each sample consisted of approximately
60 specimens (foragers) taken on the 10th (control II, EM IIa/EM IIb), 20th (control III, EM IIIa/EM IIIb),
30th (control IV, EM IVa/EM IVb), and 40th (control V, EM Va/EM Vb) day after the initial sampling
(conducted prior to the first feeding session; control I, EM Ia/EM Ib).
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2.1.3. Examinations and Estimating the Strength of Honey Bee Colonies
Clinical signs of diseases, the presence of queen and mortality of the honey bees were checked on
every inspection of the honey bee colonies at the experimental apiary. The Liebefeld method for visual
determination of the number of adult bees as well as the brood amount was performed to estimate
the strength of honey bee colonies [47], for experimental vs. control groups. The assessment of honey
bee colony strength was conducted on the 1st (I) and 40th (II) day of the experiment, during morning
hours, (9:00 to 10:00 a.m.), before the first massive forage flights of bees. For an easier assessment
of comb areas covered with bees or brood, the frame for the LR hive divided with a plastic grid to
1 × 1 dm quadrants was used.
2.1.4. Determination of Nosema spp. Infection Levels
Honey bees were counted in each sample; their abdomens were separated, thoroughly crushed,
and homogenized in a plastic container loaded with 1 mL of pure water per one bee specimen. Nosema
spp. spores were counted in each sample using a Malassez hemocytometer, and the infection levels were
calculated according to the Office International des Epizooties guidelines (OIE) [48]. Each counting
procedure was repeated three times. The counting equipment was carefully washed after each sample
counting in order to avoid contamination with spores from the previous sample.
2.2. Trials in Laboratory-Controlled Conditions
2.2.1. Trial Design in Incubators and Sampling of Adult Bees
For the trial in the laboratory conditions we collected five frames with a sealed brood from five
honey bee colonies (A. m. carnica) kept at the Agricultural institute of Slovenia in Ljubljana, Slovenia.
The colonies were free of Nosema spp. spores and showed no clinical signs of any disease. The frames
were put in an incubator at 34 ◦C and left overnight. The plastic cake-like CD-storage boxes (~8 cm
(H) × ~12 cm (dia.)) were prepared by drilling ~80 circular ventilation holes (each ~2 mm wide),
in the top cover. Moreover, two additional holes (12 mm diameter) were added as place-holders for
plastic feeding tubes. The next day we collected newly emerged honey bees and put them in the
boxes, (~50 adult bees in each box). There were three treated groups of bees feed with the sugar syrup
supplemented with 2.5, 5, and 10% EM® for bees, and the control group feed with pure sugar syrup.
Each group had five replicates. Cane sugar and drinking water were mixed 1:1 (w:v) and warmed to
40 ◦C. For the treated groups, 2.5, 5, or 10% of EM® probiotic for bees was added to the sugar syrup
(2.5, 5, or 10 g of probiotic/100 g sugar syrup). Bees in cages were fed ad libitum. We also put a tube with
drinking water into each box. Food consumption was recorded daily and food was freshly prepared
every two days. Dead bees were counted daily.
2.2.2. Hemolymph Collection
Sampling of hemolymph was done on day 11 and 15 for immunological parameters and on days
13 and 22 for biochemical parameters. Hemolymph was collected as a pool of 3 to 5 adult bees per
group, according to the method described in Beebook [49]. Hemolymph was separately collected
in vials and Eppendorf tubes for different biochemical analysis (glucose, trehalose, total lipids, total
proteins, vitellogenin). All samples were stored at −80 ◦C until analysis.
2.2.3. Biochemical Parameters
Glucose, Trehalose, and Lipid Concentrations
The hemolymph sugar content was determined using a commercially available kit (Glucose (GO)
Assay Kit, Sigma-Aldrich, Saint Louis, MO, USA). Briefly, the glucose in a sample is oxidized to
gluconic acid and hydrogen peroxide. Hydrogen peroxide reacts with o-dianisidine in the presence
of peroxidase to form a colored product. The intensity of a color is proportional to the glucose
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concentration. The optical density was measured at 540 nm using the spectrophotometer (Shimadzu,
Marlborough, MA, USA). The exact amount of glucose was calculated from the standard curve
and multiplied by the dilution factor. In the trehalose quantification, the molecule of trehalose
was hydrolyzed to two molecules of D-glucose in a reaction catalyzed by enzyme trehalase [49].
The trehalose concentration was calculated as the reading of the proper reaction minus the prior
determined glucose concentration in the same sample. The obtained results are multiplied by the
molecular weight of trehalose (342.3 g/Mol) and divided by 2× the molecular weight of glucose
(180 g/Mol) because the trehalose splits trehalase into two glucose molecules.
Total lipids in the samples were determined by the sulpho-phospho-vanillin method [50].
The hemolymph sample was mixed with 200 µL of sulphuric acid (Sigma-Aldrich, St. Louis, MO, USA)
and incubated (10 min, 100 ◦C). After quick cooling on ice, vanillin was added (2 mL, 13 mM in 66.8%
phosphoric acid) (Sigma-Aldrich, St. Louis, MO, USA). Following 30 min of incubation at the room
temperature, the optical density was measured at 546 nm using the spectrophotometer (Shimadzu,
Marlborough, MA, USA). The concentration of total lipids was calculated from a standard calibration
curve obtained from the serial dilution of oleic acid.
2.2.4. Immunological Parameters
Concentrations of Total Proteins and Vitellogenin in Hemolymph
The total protein concentration in honey bee’s hemolymph was measured according to the
Bradford method (commercial kit from Bio-Rad Hercules, Berkeley, CA, USA). To prevent melanisation
of hemolymph, the samples were held on ice during analyses. The optical density was measured
at 595 nm using the spectrophotometer (Shimadzu, Marlborough, MA, USA). The exact amount of
total protein was calculated from a standard calibration curve prepared from bovine serum albumin
(Sigma-Aldrich, St. Louis, MO, USA).
The concentration of vitellogenin (VG) was measured using a Vitellogenin Elisa kit (MyBioSource,
San Diego, CA, USA) according to the manufacturer’s instructions. This kit is based on VG antibody-VG
antigen interactions (immunosorbency) and an HRP colorimetric detection system. The optical density
was measured at 450 nm using the spectrophotometer (Shimadzu, Marlborough, MA, USA). The level
of vitellogenin in a sample was calculated from a calibration curve.
Hypopharyngeal Gland Size
On the 11th (I) and 15th (II) day of the experiment the honey bees (N = 5 per diet: EM 5%, EM
10%, control) were shortly (~5 min) held in the freezer and then HPGs were dissected and prepared
for histological examination and acinar diameter measuring. In group 2.5% EM the HPGs were not
analyzed. The HPG tissue was fixated in 10% formaldehyde, dehydrated through a series of ethanol
solution (70%, 80%, 90%, 100%; 24 h each), then 100% 2-propanol (24 h), 100% 2-propanol (12 h), 100%
2-propanol (24 h), 2-propanol: Paraffin wax (1:1, 24 h), 3× paraffin wax (24 h each), and embedded in
paraffin wax. The wax blocks were cut with microtome (Leica RM2255, Biosystems Nussloch GmbH,
Nussloch, Germany) on 7 µm thick cuts and placed on microscopic glass slides. Then, the microscopic
slides were stained with Hematoxylin & Eosin [51]. HPGs were measured using the AxioVision 4.6
program (Carl Zeiss, San Diego, CA, USA). Measuring of the HPGs acini diameter was performed on 5
to 24 acini per bee and the average diameter per group was calculated.
2.3. Statistical Analyses
In order to assess and verify the differences in the spore load data between groups at different
sampling dates, the one-way analysis of variance (ANOVA) with Turkey’s Post Hoc test for multiple
comparisons and Mann-Whitney U test were performed using the statistical software package
GraphPad Prism software version 7.00 for Windows (GraphPad Software, La Jolla, CA, USA). Data
were checked for normality using the Shapiro Wilk Test. The results are presented as the mean values
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and standard deviations. The significance level of α = 0.05 was set to define statistical differences
(0.95 confidence interval).
3. Results
3.1. Strength of Honey Bee Colonies
Variations in the average number of honey bees per group during two estimation dates are shown
in Figure 1. The statistically significant differences in honey bee colony strength between control and
experimental groups were determined on day 40 (p < 0.001; F = 17.71). A higher number of bees was
estimated in the EM II group compared to control II, while the colony strength of control I and EM I
group was similar.
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3.2. Estimation of Nosema spp. Infection Levels
A continuous decline in the Nosema spp. infection levels in honey bee colonies fed with sugar
syrup supplemented with EM® for bees on given sampling dates (days) was confirmed as statistically
significant by the ANOVA test (F = 10.12; p < 0,0001), as presented in Figure 2. A decline in the number
of Nosema spp. spores in adult bee samples originated from the honey bee colonies fed with EM®
for bees (a, b) on the second sampling date (day 10) (p < 0.01), though a statistically lower number
of spores in comparison to the initial field experiment day was already observed. A decline in the
number of spores was confirmed for each subsequent sampling date, on day 20th (only for a), 30th,
and 40th (p < 0.001), respectively.
Moreover, in the experimental group a, the reduced numbers of spores compared to the initial
spore count at an average of 47.91% on day 10; 92.12% on day 20; 93.49% on day 30, and 91.74% on
day 40, were determined. In the experimental group b, the spores reduction counts compared to the
initial spore count at an average, were as follows: 67.01% on day 10; 85.3% on day 20; 92.14% on day
30, and 95.66% on day 40 after the initial sampling.
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Figure 2. Number of Nosema spp. spores per honey bee during additional feeding in field conditions;
(a) food application by spraying, (b) food application in feeders. * p < 0.01, ** p < 0.001 (statistically
significant difference between sampling days for experimental group EM); # p < 0.01 (Control I vs. EM
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3.3. Adult Bees’ Mortality and Consumption of Diets
Mortality analyses of adult honey bees during trials in laboratory-controlled conditions revealed
significant differences in survival between the two supplemented groups (EM 2.5% and EM 10%),
as well as between the mentioned experimental groups and control group (Figure 3).
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The honey bees revealed no significant difference in cumulative diet consumption during trials in
laboratory-controlled conditions, between the three experimental groups (EM 2.5%, EM 5%, EM 10%),
as well as between the mentioned experimental groups and control group (Figure 4). The ean
cu ulative consu ption per control group as 1077.58 µL and for experi ental groups (E 2.5 ,
E 5 , E 10 ) ere 1256.12, 1254.50, and 1040.54 µL, respectively.
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3.4. Biochemical Parameters
The carbohydrates concentrations were significantly higher in the hemolymph of bees in
experimental groups (Figure 5) (F = 14.23; p < 0.0001), compared to the control. Moreover, the glucose
concentration was significantly higher in experimental groups compared to the control: 13 days old
bees from group EM 5% (p < 0.01), as well as 22-day-old bees from groups EM 5% and EM 10%.
Trehalose concentrations in honey bee hemolymph sampled on the 13th and 22nd day were also
higher in EM groups in comparison with their controls (F = 16.55; p < 0.0001). In detail, trehalose
concentrations in experimental group EM 5% was statistically higher than in the control (p < 0.001;
p < 0.0001), and similar results were obtained for experimental group EM 10% (p < 0.01; p < 0.0001),
in both observed occasions. The carbohydrate concentrations (glucose, trehalose) determined in the
control group were relatively stable during the whole studied period.
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22nd day of the experiment in laboratory-controlled conditions for control and experimental groups
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The concentration of total lipids in adult bee’s hemolymph varied during the whole observation
period, and there were no significant differences determined among the control and experimental
groups (Figure 6). The mean lipid concentrations in hemolymph of 13-day-old bees in the control
group were 2.130 mg/µL and experimental groups EM 2.5%, EM 5%, and EM 10% were 1.940, 2.690,
and 2.705 mg/µL, respectively. In a second sampling occasion, the lipid concentrations in the control
were 2.585 and in experimental groups EM 2.5%, EM 5%, and EM 10% varied as follows: 2.800, 3.300,
and 2.200 mg/µL.
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3.5. Immunological Parameters
The total proteins concentration in hemolymph was significantly higher only in experimental
group EM 5% in 15-day old bees compared with other examined .
The concentrations f vitellogenin were significantly hig e hemolymph of adult bees in
EM experimental groups, compared with their pertaining controls, but just those fed ith addition of
EM 5% and EM 10% in the first; and EM 5% in a second sampling date (F = 23.29, p < 0.0001, Figure 7).
Vitellogenin concentrations in EM 2.5% in the first and in EM 10% in the second sampling occasion
were similar to their pertaining controls.Insects 2020, 11, x FOR PEER REVIEW 10 of 17 
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Figure 7. Total proteins and vitellogenin concentrations in honey bee hemolymph sampled on the 11th
and 15th day of trail in laboratory-controlled conditions, for control and experimental groups (EM 2.5%,
EM 5%, EM 10%). Asterisks indicate statistically significant differences, Control vs. EM 5% and EM
10% on the first and EM 5% on both observed dates, * p < 0.01; mean ± SD.
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3.6. Effect of EM Supplementary Nutrition Regime on Hypopharyngeal Gland Size
The acini diameter of HPGs of 11-day-old bees from EM 5% and EM 10% fed experimental
groups was significantly larger than in the bees fed with pure sugar syrup, in the same age (F = 17.41;
p < 0.0001). No differences were established between the control and experimental groups in 15-day-old
bees. Results are shown in Figure 8.
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Figure 8. Hypopharyngeal glands acini diameter (µm), dissected from the 11 (I) and 15 (II) days old adult
honey bees, during trials in laboratory-controlled conditions, for control (Control) and experimental
groups (EM 5%, EM 10%). Asterisks indicate statistically significant differences comparing the mean
acini diameters between diets per group and represent a * p < 0.0001 level of significance; mean ± SD.
4. Discussion
EM® for bees has been successfully used by beekeepers in Croatia and neighboring countries
for the last few years. There are no available scientific reports about EM® for bees effects on honey
bee colonies life and health. Due to that, we considered that it is crucial to investigate its potential
as a therapeutic and immunomodulatory food supplement. To our knowledge, this is the first study
aim to investigate the effects of EM® for bees on honey bee colonies health condition and to address
some gaps in knowledge of therapeutical, biochemical, and immunological parameters of honey bees
exposed to probiotic treatments, in field and laboratory conditions. Except for the beekeepers reports
which do not necessarily imply positive effects, there are published controversial records of improper
protein supplementation [52–54], as well as side effects of the use of some other commercial pro- and
prebiotics [55]. Opposite to the last reported results [55], in our experiment conducted in combined field
and laboratory conditions, EM® for bees supplement induced a significant decrease in the N. ceranae
infection level along with increased values of some parameters of the immune system response.
Changes in the honey bee colonies’ strength trends were different between experimental and
control groups, but within the expected ranges under the study and environmental conditions.
Significantly stronger colonies of the experimental group at the end of the observed period were
detected. These results were in accordance with previously published scientific records on multiple
feedings with sugar syrup supplemented with herbal extracts [56,57] and using probiotics, mostly
of the genera Lactobacillus and Bacillus isolated from the A. mellifera intestines, as well as the human
probiotics which stimulates the queen on egg laying [58–61].
The results of this study demonstrated that EM® for bees administrated via a sugar syrup clearly
reduce the development of the microsporidium N. ceranae in the honey bee gut. This was observed
in the significantly lower spore counts in experimental groups compared to their pertaining control
group observed from the initial time point on the 10th, 20th, 30th, and 40th day of the field experiment
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(Figure 2). It is known that bees invaded with N. ceranae and fed with natural beebread show higher
microbiota stability and lower mortality rates than those fed only with sugar syrup [62]. Due to this fact,
we chose a field experiment where colonies were provided with natural protein food sources, except
with additional food. The control honey bee colonies showed lower average reduction of N. ceranae
spores and were on similar infection levels during the whole experimental period. Slightly better
results were obtained for experimental group a, with an application of EM® for bees by the drenching
method in comparison to colonies where food was offered in feeders (b), what can be explained with
more efficient food supplement distribution on the account of adult bees’ social behavior [63]. Other
scientific reports regarding the ability of different bacterial strains to suppress the infection level of
N. ceranae, after oral administration, also showed positive results, e.g., effects of Parasaccharibacter
apium [64], Bifidobacterium, and Lactobacillus strains [38] in laboratory conditions; and Bacillus subtilis
and Lactobacillus johansonii under realistic field conditions [59,60]. Except for good results in the
nosemosis growth inhibition, the beneficial effects linked with the queen’s production, reducing of
V. destructor mites number [65], increased honey production [59,65,66], and increase of larvae and adult
bees’ viability [34,67] were reported. Given that analyzing the percentage of forager bees infected by
Nosema spp. spores was previously demonstrated to be a more accurate method of estimating the level
of infection at the colony level [68], we applied this method to examine the therapeutic capacity of EM®
for bees as a dietary supplement. According to the results presented in this study, and the excellent
results in other studies on biological and therapeutic effects for different disorders in animals, plants,
and the environment [69–73], it should be acknowledged that EM® holds a substantial potential for
nosemosis treatment.
Mortality rate analyses of adult honey bees during trials in laboratory-controlled conditions
revealed a significant difference between control and experimental groups, especially for 10% EM.
The results related with survival rates of bees in laboratory conditions reported by Maistrello et al. [74]
and Arredondo et al. [34] were more advantageous, in comparison with our results. Observations at
apiary conditions indicate the absence of negative impacts of EM® for bees on brood and adult bee’s
health and survival.
We found that adult bees originating from the experimental groups during trials in
laboratory-controlled conditions consumed similar amounts of the food compared to the control
groups. On the contrary, previous studies reported that bees ate higher amounts of the supplemented
food [75].
In our study, the levels of carbohydrates (glucose, trehalose) were statistically higher in the
experimental groups of honey bee colonies. Usually, the concentrations of carbohydrates are stable
during the year, but they rapidly increase when hemolymph sampling is conducted the day after
autumn’s administration of sugar syrup in hives [76]. Moreover, some authors suggest that due to
different sugar degradation pathways the beneficial microbes could more successfully colonize a sugar
rich digestive system in bees [77]. In accordance, we found the lipid content to be very stable during
both hemolymph sampling dates with no significant differences between control and experimental
groups, not surprisingly in respect to the carbohydrate diet of caged honey bees in laboratory conditions.
Those results were contrary to results of Chakrabarti et al. [75].
Nevertheless, despite the diet type, concentrations of proteins were increased in the EM 5%
experimental group, 15 days after the experiment in control laboratory conditions started. Those results
are in accordance with previous reports on the impact of dietary sterols on various fitness traits in
insects [75]. Although the vitellogenin key role is reproduction, except in the queen, it can be detected
at high concentrations in sterile workers hemolymph [78]. As vitellogenin hemolymph titers are
linked with honey bee immunity [79] and are able to bind to multiple pathogens [80], we chose to
investigate their concentration in the hemolymph of adult bees that originate from experimental and
control groups. Moreover, considering the fact that beneficial microorganisms could stimulate the
host’s immune response and improve the resistance to diseases [81] is especially important because
infection with N. ceranae can depress the honey bee immune system [82]. In our study, vitellogenin
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concentrations in hemolymph sampled on the 11th and 15th day of trials in laboratory-controlled
conditions showed a significant increase in group EM 5% and EM 10% on the first and EM 5% on both
observed occasions, compared with their controls. Despite the finding that the increased HPG size does
not always represent a good physiological status [13] or even appears as a result of negative effects of
nutritional stress and dysbiosis [19], we noticed an increase in HPG size and vitellogenin concentration
in younger bees that were fed with the EM probiotic. The results can be explained by the fact that the
physiological status of bees reacted positively with the presence of beneficial microbes in the food,
taking into consideration that HPGs host bacterial communities respond differently depending on
the food quality [19]. In addition, there are changes in bacterial loads and community composition in
different seasons and tasks of bees (nurses, foragers, winter bees) due to the different food [83] that is
available in nature or stored in the hive.
In practice, the beekeepers treat honey bee colonies against varroosis using veterinary medicines.
In the case of infection with another pathogen including Nosema spp., the careful use of commercial
probiotics with beneficial microorganisms, considering their metabolites production, may represent
a natural tool for protecting or reducing the load with pathogens in honey bees. In our opinion,
this study shows the possible role of beneficial bacteria supplementation in supporting honey bee
health as a preventive measure and new tool for the management of the bee microbiome. Further
studies are necessary to investigate the efficacy of the EM probiotic on honey bee colonies in different
seasons and evaluate possible effects on honey production.
5. Conclusions
Due to the fact that numerous negative factors contribute to a decline in insect pollinators, it is
fundamental to research all the nutritional requirements crucial to improve and sustain the honey bee
colonies health. EM® for bees is a promising alternative food additive for nosemosis combating in
honey bee colonies causing consecutive reductions in spore counts after proper in hive administration.
Overall, this is the first study reporting the revealed novel insights about the EM® for bees uptake
benefits and its role in honey bee nutritional physiology.
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69. Laskowska, E.; Jarosz, L.; Grądzki, Z. Effect of Multi-Microbial Probiotic Formulation Bokashion Pro-
and Anti-Inflammatory Cytokines Profilein the Serum, Colostrum and Milk of Sows, and in a Culture
of Polymorphonuclear Cells Isolated from Colostrum. Probiotics Antimicrob. Proteins. 2019, 11, 220–232.
[CrossRef]
70. Pinoargote, G.; Flores, G.; Cooper, K.; Ravishankar, S. Effects on survival and bacterial community composition
of the aquaculture water and gastrointestinal tract of shrimp (Litopenaeus vannamei) exposed to probiotic
treatments after an induced infection of acute hepatopancreatic necrosis disease. Aquac. Res. 2018, 49, 1–19.
[CrossRef]
71. Rozaik, E.; Safwat, S. Growth Inhibition of Various Pathogenic Microorganisms Using Effective
Microorganisms (EM). Int. J. Appl. Eng. Res. 2018, 4, 283–286. [CrossRef]
72. Zaman, A.; Ahmed, M.; Gogoi, P. Effect of bokashi on plant growth, yield and essential oil quantity and
quality in patchouli (Pogostemon Cablin Benth.). Biosci. Biotech. Res. Asia 2010, 7, 383–387.
73. Olle, M.; Williams, I. The Influence of Effective Microorganisms on the Growth and Nitrate Content of
Vegetable Transplants. J. Adv. Agric. Technol. 2015, 2, 1. [CrossRef]
74. Maistrello, L.; Lodesani, M.; Costa, C.; Leonardi, F.; Marani, G.; Caldon, M.; Mutinelli, F.; Granato, A.
Screening of natural compounds for the control of nosema disease in honeybees (Apis mellifera). Apidologie
2008, 39, 436–445. [CrossRef]
75. Chakrabarti, P.; Lucas, H.M.; Sagili, R.R. Evaluating effects of a critical micronutritient
(24-methylenecholesterol) on honeybee physiology. Ann. Entomol. Soc. Am. 2020, 113, 176–182. [CrossRef]
76. Kunc, M.; Dobeš, P.; Hurychová, J.; Vojtek, L.; Poiani, S.B.; Danihlík, J.; Havlík, J.; Titěra, D.; Hyršl, P. The Year
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